We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

IsoPlexis Proteomic Product Suite for NK Cells

Learn how IsoPlexis’ functional proteomics reveals unique secretomic signatures and insights into NK Cells.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Predictive durability biomarkers with a combination PEG-IL2 and checkpoint therapy
Clinical immune monitoring with immune checkpoint inhibitor therapies
Early indicators of patient response and relapse with immune checkpoint inhibitor therapies
Identifying therapeutic targets driving COVID inflammation
Mechanisms of immune persistence in solid tumor indications
Early indicators of potency in a combination immune checkpoint and TIL Therapy, and much more!
A Deeper Look

More about this

Overcoming Challenges in NK Cell Research

Immune monitoring is critical in therapeutic development to understand how cellular functional phenotype influences therapeutic efficacy and disease progression. However, challenges such as limited persistence and tumor evasion test the durability and efficacy of these novel therapies.

Download this App Note to learn how IsoPlexis researchers better understand the functional mechanisms of NK cell potency and persistence.

Get the